BLYS, a protein that stimulates antibody production, is being tested in patients with CVID. The trial aims to determine the efficacy of BLyS in producing antibodies and warding off infections.
Scientists at Human Genome Sciences and the CRC Beatson Institute discovered a new protein that blocks a key receptor on eosinophils, cells that induce allergic reactions. This breakthrough could lead to the development of a new drug to treat asthma and allergies.
Researchers at UCLA and Human Genome Sciences have discovered two human proteins, METH-1 and METH-2, that inhibit blood vessel formation and show promise in treating a range of cancer tumors. The proteins were found to be more potent than endostatin in preventing new blood vessel growth.
The discovery of BLyS, a natural component of the immune system, holds promise for treating immune deficiency disorders, enhancing vaccine effectiveness, and targeting certain types of leukemia and lymphoma. The substance stimulates B cell growth and antibody production, addressing a long-standing puzzle about monocytes' role in the im...